Bcl2-interacting killer CpG methylation in multiple myeloma: A potential predictor of relapsed/refractory disease with therapeutic implications

Leukemia and Lymphoma

Volumn 53, Issue 9, 2012, Pages 1709-1713

  Hatzimichael, Eleftheria ^a,b   Dasoula, Aggeliki ^a   Kounnis, Valentinos ^b   Benetatos, Leonidas ^a   Nigro, Cristiana Lo ^c   Lattanzio, Laura ^c   Papoudou Bai, Alexandra ^a   Dranitsaris, George ^d   Briasoulis, Evangelos ^a,b   Crook, Tim ^e  

^a UNIVERSITY HOSPITAL OF IOANNINA   (Greece)

^b UNIVERSITY OF IOANNINA   (Greece)

^c S CROCE E CARLE HOSPITAL   (Italy)

^d PRINCESS MARGARET HOSPITAL   (Canada)

^e BASILDON HOSPITAL   (United Kingdom)

Author keywords

Bcl 2 superfamily; BIK; Methylation; multiple myeloma; relapsed refractory

Indexed keywords

ALBUMIN; BETA 2 MICROGLOBULIN; PROTEIN BCL 2;

ADULT; ALBUMIN BLOOD LEVEL; ANEMIA; ARTICLE; BONE DISEASE; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CPG ISLAND; DISEASE COURSE; DNA METHYLATION; FEMALE; HUMAN; HUMAN CELL; LOGISTIC REGRESSION ANALYSIS; MALE; MULTIPLE MYELOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RELAPSE; RISK; VALIDATION STUDY;

AGED; APOPTOSIS REGULATORY PROTEINS; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MEMBRANE PROTEINS; MULTIPLE MYELOMA; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; PROGNOSIS; RECURRENCE;

EID: 84864969911     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2012.661854     Document Type: Article

References (27)

1. Hanahan D, Weinberg RA. Hallmarks of cancer: The next generation. Cell 2011;144:646-674.
2. H anahan D.Weinberg RA. Th e hallmarks of cancer. Cell 2000;100:57-70.
3. Liu X, Dai S, Zhu Y, et al. Th e structure of a Bcl-xL/Bim fragment complex: Implications for Bim function. Immunity 2003;19:341-352.
4. K elekar A, Th ompson CB. Bcl-2-family proteins: The role of the BH3 domain in apoptosis. Trends Cell Biol 1998;8:324-330.
5. Bouillet P, Strasser A. BH3-only proteins-evolutionarily conserved proapoptotic Bcl-2 family members essential for initiating programmed cell death. J Cell Sci 2002;115:1567-1574.
6. Boyd JM, Gallo GJ, Elangovan B, et al. Bik, a novel death-inducing protein shares a distinct sequence motif with Bcl-2 family proteins and interacts with viral and cellular survival-promoting proteins. Oncogene 1995;11:1921-1928.
7. L omonosova E, Chinnadurai G. BH3-only proteins in apoptosis and beyond: An overview. Oncogene 2008;27(Suppl. 1):S2-S19.
8. G ermain M, Mathai JP, McBride HM, et al. Endoplasmic reticulum BIK initiates DRP1-regulated remodelling of mitochondrial cristae during apoptosis. EMBO J 2005;24:1546-1556.
9. Chinnadurai G, Vijayalingam S, Rashmi R. BIK, the founding member of the BH3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes. Oncogene 2008;27(Suppl. 1):S20-S29.
10. Hur J, Chesnes J, Coser KR, et al. Th e Bik BH3-only protein is induced in estrogen-starved and antiestrogen-exposed breast cancer cells and provokes apoptosis. Proc Natl Acad Sci USA 2004;101:2351-2356.
11. Reis PP, Rogatto SR, Kowalski LP, et al. Quantitative real-time PCR identifi es a critical region of deletion on 22q13 related to prognosis in oral cancer. Oncogene 2002;21:6480-6487.
12. C astells A, Ino Y, Louis DN, et al. Mapping of a target region of allelic loss to a 0.5-cM interval on chromosome 22q13 in human colorectal cancer. Gastroenterology 1999;117:831-837.
13. K im TY, Zhong S, Fields CR, et al. Epigenomic profi ling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma. Cancer Res 2006;66:7490-7501.
14. D ai Z, Liu S, Marcucci G, et al. 5-Aza-2 -deoxycytidine and depsipeptide synergistically induce expression of BIK (BCL2-interacting killer). Biochem Biophys Res Commun 2006;351:455-461.
15. P ompeia C, Hodge DR, Plass C, et al. Microarray analysis of epigenetic silencing of gene expression in the KAS-6/1 multiple myeloma cell line. Cancer Res 2004;64:3465-3473.
16. F ennell DA, Chacko A, Mutti L. BCL-2 family regulation by the 20S proteasome inhibitor bortezomib. Oncogene 2008;27:1189-1197.
17. Z hu H, Zhang L, Dong F, et al. Bik/NBK accumulation correlates with apoptosis-induction by bortezomib (PS-341, Velcade) and other proteasome inhibitors. Oncogene 2005;24:4993-4999.
18. R ichardson P, Mitsiades C, Schlossman R, et al. Th e treatment of relapsed and refractory multiple myeloma. Hematology Am Soc Hematol Educ Program 2007:317-323.
19. R ozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000;132:365-386.
20. A ltschul SF, Madden TL, Schaffer AA, et al. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 1997;25:3389-3402.
21. Sturm I, Stephan C, Gillissen B, et al. Loss of the tissue-specifi c proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma. Cell Death Diff er 2006;13:619-627.
22. Bouillet P, Metcalf D, Huang DC, et al. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science 1999;286: 1735-1738.
23. V illunger A, Scott C, Bouillet P, et al. Essential role for the BH3-only protein Bim but redundant roles for Bax, Bcl-2, and Bcl-w in the control of granulocyte survival. Blood 2003;101:2393-2400.
24. Kuribara R, Honda H, Matsui H, et al. Roles of Bim in apoptosis of normal and Bcr-Abl-expressing hematopoietic progenitors. Mol Cell Biol 2004;24:6172-6183.
25. K uroda J, Puthalakath H, Cragg MS, et al. Bim and Bad mediate imatinib-induced killing of Bcr/Abl leukemic cells, and resistance due to their loss is overcome by a BH3 mimetic. Proc Natl Acad Sci USA 2006;103:14907-14912.
26. Z hao Y, Tan J, Zhuang L, et al. Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim. Proc Natl Acad Sci USA 2005;102:16090-16095.
27. Amundson SA, Myers TG, Scudiero D, et al. An informatics approach identifying markers of chemosensitivity in human cancer cell lines. Cancer Res 2000;60:6101-6110.